<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font27">and </span>
   <span class="font18">for </span>
   <span class="font16">antibody </span>
   <span class="font15">viral </span>
   <span class="font14">with </span>
   <span class="font14">antibodies </span>
   <span class="font14">virus </span>
   <span class="font14">[]. </span>
   <span class="font14">against </span>
   <span class="font13">are </span>
   <span class="font13">that </span>
   <span class="font12">protein </span>
   <span class="font12">have </span>
   <span class="font12">human </span>
   <span class="font12">{background </span>
   <span class="font12">monoclonal </span>
   <span class="font12">from </span>
   <span class="font12">binding </span>
   <span class="font11">therapeutic </span>
   <span class="font11">been </span>
   <span class="font11">can </span>
   <span class="font11">cells </span>
   <span class="font11">fragments </span>
   <span class="font11">margin </span>
   <span class="font11">The </span>
   <span class="font11">{border-style </span>
   <span class="font11">mAbs </span>
   <span class="font11">neutralizing </span>
   <span class="font11">px;} </span>
   <span class="font11">treatment </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">HIV- </span>
   <span class="font11">was </span>
   <span class="font11">also </span>
   <span class="font11">infection </span>
   <span class="font11">receptor </span>
   <span class="font11">target </span>
   <span class="font11">targets </span>
   <span class="font11">this </span>
   <span class="font11">affinity </span>
   <span class="font11">al. </span>
   <span class="font11">[], </span>
   <span class="font11">cell </span>
   <span class="font11">domain </span>
   <span class="font11">potential </span>
   <span class="font11">respiratory </span>
   <span class="font11">viruses </span>
   <span class="font11">They </span>
   <span class="font11">antiviral </span>
   <span class="font11">clinical </span>
   <span class="font11">designed </span>
   <span class="font11">its </span>
   <span class="font11">such </span>
   <span class="font11">their </span>
   <span class="font11">used </span>
   <span class="font11">variable </span>
   <span class="font11">different </span>
   <span class="font11">has </span>
   <span class="font11">recombinant </span>
   <span class="font11">single </span>
   <span class="font10">detection </span>
   <span class="font10">diseases </span>
   <span class="font10">engineering </span>
   <span class="font10">fragment </span>
   <span class="font10">other </span>
   <span class="font10">two </span>
   <span class="font10">which </span>
   <span class="font10">antigen </span>
   <span class="font10">chain </span>
   <span class="font10">developed </span>
   <span class="font10">development </span>
   <span class="font10">high </span>
   <span class="font10">new </span>
   <span class="font10">proteins </span>
   <span class="font10">scFv </span>
   <span class="font10">targeting </span>
   <span class="font10">virus, </span>
   <span class="font10">Ebola </span>
   <span class="font10">HIV </span>
   <span class="font10">These </span>
   <span class="font10">bispecific </span>
   <span class="font10">hepatitis </span>
   <span class="font10">more </span>
   <span class="font10">COVID- </span>
   <span class="font10">blocking </span>
   <span class="font10">cells. </span>
   <span class="font10">diagnostic </span>
   <span class="font10">display </span>
   <span class="font10">host </span>
   <span class="font10">infected </span>
   <span class="font10">influenza </span>
   <span class="font10">potent </span>
   <span class="font10">prevention </span>
   <span class="font10">px; </span>
   <span class="font10">rabies </span>
   <span class="font10">showed </span>
   <span class="font10">specific </span>
   <span class="font10">study, </span>
   <span class="font10">targets. </span>
   <span class="font10">therapy </span>
   <span class="font10">these </span>
   <span class="font10">three </span>
   <span class="font10">{font-family </span>
   <span class="font10">This </span>
   <span class="font10">Virol. </span>
   <span class="font10">Virus </span>
   <span class="font10">Whole </span>
   <span class="font10">antibodies. </span>
   <span class="font10">antigens </span>
   <span class="font10">based </span>
   <span class="font10">but </span>
   <span class="font10">coronavirus </span>
   <span class="font10">entry </span>
   <span class="font10">font-size </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">immune </span>
   <span class="font10">infections </span>
   <span class="font10">infections. </span>
   <span class="font10">interaction </span>
   <span class="font10">library </span>
   <span class="font10">mAb </span>
   <span class="font10">single-chain </span>
   <span class="font10">specificity </span>
   <span class="font10">surface </span>
   <span class="font10">were </span>
   <span class="font10">Inhibition </span>
   <span class="font10">Opin. </span>
   <span class="font10">RSV </span>
   <span class="font10">antibodies, </span>
   <span class="font10">approved </span>
   <span class="font10">between </span>
   <span class="font10">both </span>
   <span class="font10">cellular </span>
   <span class="font10">design </span>
   <span class="font10">double; </span>
   <span class="font10">envelope </span>
   <span class="font10">including </span>
   <span class="font10">many </span>
   <span class="font10">most </span>
   <span class="font10">not </span>
   <span class="font10">novel </span>
   <span class="font10">phage </span>
   <span class="font10">primary </span>
   <span class="font10">research </span>
   <span class="font10">severe </span>
   <span class="font10">single-domain </span>
   <span class="font10">spike </span>
   <span class="font10">syncytial </span>
   <span class="font10">technology </span>
   <span class="font10">than </span>
   <span class="font10">there </span>
   <span class="font10">using </span>
   <span class="font10">various </span>
   <span class="font10">vitro </span>
   <span class="font10">Antibodies </span>
   <span class="font10">Antibody </span>
   <span class="font10">Biol. </span>
   <span class="font10">Elsevier </span>
   <span class="font10">HPV </span>
   <span class="font10">IgG </span>
   <span class="font10">Infect. </span>
   <span class="font10">There </span>
   <span class="font10">VHH </span>
   <span class="font10">activity </span>
   <span class="font10">being </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">class </span>
   <span class="font10">could </span>
   <span class="font10">diagnosis </span>
   <span class="font10">drug </span>
   <span class="font10">effective </span>
   <span class="font10">large </span>
   <span class="font10">main </span>
   <span class="font10">mutagenesis </span>
   <span class="font10">nanobodies </span>
   <span class="font10">neutralization </span>
   <span class="font10">one </span>
   <span class="font10">patients </span>
   <span class="font10">phase </span>
   <span class="font10">properties </span>
   <span class="font10">region </span>
   <span class="font10">scFvs </span>
   <span class="font10">solid; </span>
   <span class="font10">some </span>
   <span class="font10">syndrome </span>
   <span class="font10">through </span>
   <span class="font10">trispecific </span>
   <span class="font10">use </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">ACE </span>
   <span class="font10">ALX- </span>
   <span class="font10">Although </span>
   <span class="font10">CCR </span>
   <span class="font10">Chem. </span>
   <span class="font10">Human </span>
   <span class="font10">Immunol. </span>
   <span class="font10">Med. </span>
   <span class="font10">Microbiol. </span>
   <span class="font10">Monoclonal </span>
   <span class="font10">Phase </span>
   <span class="font10">SARS </span>
   <span class="font10">SARS-CoV- </span>
   <span class="font10">Table </span>
   <span class="font10">VNAR </span>
   <span class="font10">after </span>
   <span class="font10">agents </span>
   <span class="font10">all </span>
   <span class="font10">among </span>
   <span class="font10">anti-GP </span>
   <span class="font10">antibody-based </span>
   <span class="font10">approach </span>
   <span class="font10">approaches </span>
   <span class="font10">attachment </span>
   <span class="font10">bind </span>
   <span class="font10">biopharmaceuticals </span>
   <span class="font10">body </span>
   <span class="font10">bold </span>
   <span class="font10">centre </span>
   <span class="font10">complement </span>
   <span class="font10">considered </span>
   <span class="font10">courier; </span>
   <span class="font10">derived </span>
   <span class="font10">diabody </span>
   <span class="font10">drugs </span>
   <span class="font10">due </span>
   <span class="font10">effector </span>
   <span class="font10">efficacy </span>
   <span class="font10">em; </span>
   <span class="font10">engineered </span>
   <span class="font10">epitopes </span>
   <span class="font10">expressed </span>
   <span class="font10">free </span>
   <span class="font10">fusion </span>
   <span class="font10">generation </span>
   <span class="font10">humanized </span>
   <span class="font10">important </span>
   <span class="font10">into </span>
   <span class="font10">molecular </span>
   <span class="font10">molecule </span>
   <span class="font10">neutralize </span>
   <span class="font10">only </span>
   <span class="font10">particles </span>
   <span class="font10">pathogenic </span>
   <span class="font10">pt;} </span>
   <span class="font10">resource </span>
   <span class="font10">selected </span>
   <span class="font10">shown </span>
   <span class="font10">therapeutics </span>
   <span class="font10">they </span>
   <span class="font10">treating </span>
   <span class="font10">type </span>
   <span class="font10">types </span>
   <span class="font10">variety </span>
   <span class="font10">via </span>
   <span class="font10">virus. </span>
   <span class="font10">viruses. </span>
  </p>
 </body>
</html>
